Welcome to Metabiomics.com
Metabiomics is developing a non-invasive stool test for the early detection of colon polyps and colorectal cancer based an advanced interrogation of the human gut microbiome.
We are focused on developing a non-invasive microbiome test for the earlier and more accurate detection of colon polyps and colorectal cancer
Metabiomics is developing a pipeline of services for characterizing gut microbiome health and disease
Metabiomics is an early stage molecular diagnostics company that is developing in-vitro diagnostics, screening tests, and health assays that leverage breakthroughs in next-generation DNA sequencing, computational systems biology, and human microbiome sciences.
Investor Resources and News
Metabiomics has developed strategies for rapid commercialization and growth built on a strong technology foundation and a management team with extensive and diverse experience. Please contact us directly for more information on available investment opportunities.
Metabiomics to Present Colorectal Cancer Screening Test at Upcoming Investor Conference, OneMedForumNY 2013
POTOMAC FALLS, VA, June 21, 2013 Metabiomics, an early […]
Clinical Research News and Resources
Metabiomics conducts microbiome systems biology, molecular diagnostics, and gastroenterology clinical research in collaboration with leading medical institutions and strategic partners across the North America, Europe and Asia. Please contact us directly to explore strategic alliance, collaboration, and technology licensing opportunities.
It is not often that health sciences takes off in leaps […]
Manassas, VA (April 15, 2009) — Metabiomics© is n […]